A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis
Psutka SP, Gulati R, Jewett MAS, Fadaak K, Finelli A, Legere L, Morgan TM, Pierorazio PM, Allaf ME, Herrin J, Lohse CM, Thompson R, Boorjian SA, Atwell TD, Schmit GD, Costello BA, Shah ND, Leibovich BC. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. European Urology 2021, 81: 576-585. PMID: 34862099, PMCID: PMC10351331, DOI: 10.1016/j.eururo.2021.11.002.Peer-Reviewed Original ResearchMeSH KeywordsAdultCarcinoma, Renal CellDecision Support TechniquesHumansKidney NeoplasmsMaleNephrectomyPrecision MedicineRetrospective StudiesTreatment OutcomeConceptsCancer-specific mortalityRenal cortical massesRadical nephrectomyPartial nephrectomyActive surveillancePersonalized treatment selectionClavien gradeRisk calculatorThermal ablationTreatment selectionEastern Cooperative Oncology Group performance statusClinical T1 renal massesSurgeon/hospital volumeHigh-volume referral centerInitial radical nephrectomyCharlson Comorbidity IndexCompeting-risks regressionConsecutive adult patientsGlomerular filtration rateClavien grade 3Risk of deathBody mass indexT1 renal massesRisk of mortalityClinical decision aid